Head to head

GHRP-2 vs Sermorelin

GH secretagogue

Two compounds that are more often stacked than compared — the side-by-side data, and what actually separates them.

Verdict

Not an either/or

GHRP-2 and Sermorelin appear in each other's stacks in this dataset, so the most common real-world use is together rather than instead of. If you do have to pick one, let route and schedule decide it — GHRP-2 is subcutaneous, intramuscular, once daily; Sermorelin is subcutaneous, once daily — because the evidence does not separate them cleanly enough to do it for you.

What you are actually choosing between

Before anything else: the dataset lists GHRP-2 and Sermorelin in each other's stacks. They are run together more often than they are chosen between, so if you came here for a winner, the first honest answer is that this may not be an either/or.

Both are classed here as growth hormone secretagogues, so this is a within-class choice: the mechanism is broadly shared and what separates them is kinetics, route, and how much has actually been tested.

The overlap is recovery and sleep and muscle growth. On this site's goal weighting — an editorial priority score, not a measure of effect size — GHRP-2 rates 3/5 for recovery and sleep and Sermorelin rates 4/5. Outside that overlap only GHRP-2 goes further, carrying weight for appetite control; Sermorelin's declared goals stop at the overlap.

The evidence

Neither has an evidence edge — both sit at the same tier. GHRP-2: approval from a regulator somewhere, though not a current FDA or EMA label; registered in Japan as pralmorelin for a single-dose diagnostic test, not chronic use. Sermorelin: approval from a regulator somewhere, though not a current FDA or EMA label; it was FDA approved as Geref, then withdrawn for commercial reasons. Anyone telling you one is clearly better supported than the other is going beyond what is published.

How they differ in practice

GHRP-2 is a subcutaneous injection and an intramuscular injection; Sermorelin is a subcutaneous injection. Both are injected, so route does not decide this one.

The kinetics are roughly 5× apart — 1 h for GHRP-2 against 12 min for Sermorelin — and yet both are dosed once daily. That schedule is convention rather than clearance, which is worth knowing before you assume the two behave the same way between doses.

Risk and difficulty

Sermorelin is rated beginner here and GHRP-2 intermediate. That rating is about how much can go wrong in handling, dosing and monitoring, not about how well either works.

Source notes

What the evidence actually says

Verbatim, so you can check the verdict above against what it was built from.

GHRP-2

Synthetic hexapeptide ghrelin receptor (GHS-R1a) agonist. Unusually for this corner of the market it has real human data: it has been studied as a growth hormone secretagogue in published dose-response work, and the same molecule is registered in Japan as pralmorelin for use as a single-dose diagnostic test of growth hormone deficiency. That diagnostic use is a one-off intravenous challenge, not a chronic subcutaneous protocol, so the human evidence supports the fact that it releases growth hormone rather than the community habit of dosing it daily for months. It is not approved for physique or anti-ageing use anywhere. It is less selective than ipamorelin: expect measurable prolactin and cortisol elevation, which is the usual reason people switch away from it. The 100-300 mcg per dose range, often split into two or three doses a day, comes from practice rather than from a label.

Sermorelin

Synthetic analogue of the first 29 amino acids of GHRH. Previously approved in the US as Geref for paediatric GH deficiency and used as a diagnostic agent, then withdrawn from the market for commercial reasons. Because it works through the pituitary it preserves pulsatile GH release, but modern adult data is thin and most anti-ageing dosing is extrapolated from that older clinical use.

Side by side

The numbers

GHRP-2 compared with Sermorelin
Attribute	GHRP-2	Sermorelin
Class	GH secretagogue	GH secretagogue
Routes	Subcutaneous, Intramuscular	Subcutaneous
Dose range	100 mcg–300 mcg (typical 200 mcg)	100 mcg–1 mg (typical 300 mcg)
Frequency	Once daily	Once daily
Half-life	1 h	12 min
Cycle length	12 weeks	12 weeks
Experience	Intermediate	Beginner
Evidence	Approved elsewhere	Approved elsewhere
Contraindications	Pregnant / nursing Active malignancy Under 18	Pregnant / nursing Active malignancy Under 18
Side effects	Raises prolactin and cortisol more than ipamorelin does — this is its main practical drawback, and it scales with dose, so pushing past roughly 300 mcg per injection buys little extra growth hormone while making the hormonal spillover worse Hunger spike within about half an hour of dosing, which works against a cut Water retention, morning puffiness, and numb or tingling hands Head rush, flushing or brief light-headedness just after injection Blunted response over months of uninterrupted daily use, so it is usually cycled Injection site redness or itching	Injection site redness, swelling or itching Flushing shortly after dosing Headache or transient dizziness Water retention and tingling in the hands Vivid dreams or drowsiness when dosed pre-bed

Turn a typical dose into a mark on the syringe: GHRP-2Sermorelin

Goals

Where they overlap, and where they do not

Goal	GHRP-2	Sermorelin
recovery and sleep	GHRP-2: 3/5	Sermorelin: 4/5
muscle growth	GHRP-2: 3/5	Sermorelin: 3/5
longevity	GHRP-2: 1/5	Sermorelin: 3/5
fat loss	GHRP-2: 2/5	Sermorelin: 2/5
injury repair	GHRP-2: 2/5	Sermorelin: 2/5
appetite controlone only	GHRP-2: 3/5	Sermorelin: —

They overlap on 5 goals and diverge on 1. Weights are this site’s editorial priority score out of 5 — how central a goal is to why people use a compound. They are not effect sizes and two 5s do not mean two equal results.

Go deeper

MonographGHRP-2Mechanism, protocol, storage, sources.MonographSermorelinMechanism, protocol, storage, sources.ToolReconstitution calculatorTurn either dose above into a mark on the syringe.

Other comparisons with these two

Educational information only, not medical advice. Talk to a licensed clinician before starting, changing, or stopping anything.